Advanced Biomaterials for Drug Delivery
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Drug Delivery".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 812
Special Issue Editor
Interests: drug delivery; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomaterials have been considered for application in designing various drug delivery systems in recent decades. Because of their safety, tailorability, and suitability for various therapeutic molecules, including drugs, peptides, vaccines, antibodies, and enzymes, biomaterials have been approved for use in drug delivery via different administration routes. Through the functionalization of biomaterials, a wide range of drug delivery purposes could be achieved, including enhancing or controlling drug release. Targeting drug delivery systems based on biomaterials may play a crucial role in achieving high drug levels at the affected organ, with the desired therapeutic effect along with reduced toxicity. Hence, functionalized biomaterials could be applied for site-specific targeting of small or large drug molecules, which is essential for treating chronic diseases such as carcinomas, hepatic, cardiovascular diseases, etc.
The current Special Issue aims to present original or review articles that explore applications of advanced biomaterials in drug delivery.
Topics of interest for this Special Issue include, but are not limited to, the following:
- Sources and classes of biomaterials applied in drug delivery;
- Safety features of biomaterial-based drug delivery systems;
- Functionalization of biologically active molecules;
- Biomaterials applications in various drug delivery systems;
- Enhancing the efficacy and targeting of chemotherapeutic agents;
- Biomaterial-based nanoparticulate drug delivery systems;
- The role of biomaterials in pharmaceutical processing and manufacturing.
Prof. Dr. Mohamed Abbas Ibrahim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- advanced biomaterials
- drug delivery
- enhanced release
- controlled release
- targeted release
